Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
57,417,494
-
Number of holders
-
267
-
Total 13F shares, excl. options
-
50,193,424
-
Shares change
-
-2,940,598
-
Total reported value, excl. options
-
$1,664,235,088
-
Value change
-
-$100,697,267
-
Put/Call ratio
-
36%
-
Number of buys
-
133
-
Number of sells
-
-102
-
Price
-
$33.19
Significant Holders of Harmony Biosciences Holdings, Inc. - Common Stock, $0.00001 par value per share (HRMY) as of Q1 2025
291 filings reported holding HRMY - Harmony Biosciences Holdings, Inc. - Common Stock, $0.00001 par value per share as of Q1 2025.
Harmony Biosciences Holdings, Inc. - Common Stock, $0.00001 par value per share (HRMY) has 267 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 50,193,424 shares
of 57,417,494 outstanding shares and own 87% of the company stock.
Largest 10 shareholders include Valor Management LLC (6,618,033 shares), BlackRock, Inc. (6,511,873 shares), FMR LLC (5,342,525 shares), VANGUARD GROUP INC (4,699,353 shares), STATE STREET CORP (1,579,034 shares), AMERICAN CENTURY COMPANIES INC (1,288,787 shares), DIMENSIONAL FUND ADVISORS LP (1,224,794 shares), LSV ASSET MANAGEMENT (1,194,961 shares), GEODE CAPITAL MANAGEMENT, LLC (965,750 shares), and MARSHALL WACE, LLP (887,537 shares).
This table shows the top 267 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.